首页 > 市场调查报告书 > 医疗设备

市场调查报告书

商品编码

1509550

妊娠毒血症诊断市场：按测试类型、按产品类型、按最终用户、按地区

Preeclampsia Diagnostics Market, By Test Type, By Product Type, By End User, By Geography

出版日期: 2024年06月13日 | 出版商:

Coherent Market Insights | 英文 188 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计 2024 年全球妊娠毒血症诊断市场规模将达到 21 亿美元，预计 2031 年将达到 41.2 亿美元，2024 年至 2031 年复合年增长率为 10.1%。

图 1. 2024 年妊娠毒血症诊断市场占有率（%），依地区划分

妊娠毒血症前症是一种妊娠併发症，其特征是妊娠 20 週后出现高血压和尿液中出现蛋白质。如果未被发现，这对母亲和胎儿都可能是危险的。早期诊断至关重要，这样临床医生就可以密切监测病情，并在妊娠毒血症恶化时接生婴儿。传统的诊断方法依赖临床症状和体征，有其限制。由于对这种疾病的认识不断提高，全球妊娠毒血症诊断市场可能会成长。已经开发并采用了各种新的诊断工具来筛检高风险女性并能够及时识别疾病。

市场动态：

全球妊娠毒血症诊断市场的成长是由全球妊娠毒血症盛行率不断上升所推动的。根据最近的估计，妊娠毒血症使全球整体约 5-8% 的怀孕变得复杂。初为人母的年龄增加也导致了病例数的增加。新产品的推出和越来越多地采用先进的诊断技术进行早期筛检描述了市场成长的机会。然而，低收入地区对妊娠毒血症的认识较低以及缺乏全民健康保险可能会阻碍市场成长。新诊断设备的高成本可能是一个挑战，特别是在价格敏感的新兴市场。

本研究的主要特点

该报告对全球妊娠毒血症诊断市场进行了详细分析，以 2023 年为基准年估计了预测期内（2024-2031 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。发布。
它还揭示了各个细分市场的潜在商机，并说明了该市场有吸引力的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
该报告根据公司亮点、产品系列、主要亮点、财务绩效和策略等参数，对全球妊娠毒血症诊断市场的主要企业进行了介绍。
该报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球妊娠毒血症诊断市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
透过分析全球妊娠毒血症诊断市场时所使用的各种策略矩阵，将促进相关人员的决策。

公司简介
- Roche Diagnostic
- Thermo Fisher Giving Inc.
- PerkinElmer
- Siemens Healthineers
- Abbott Laboratories
- Beckman Coulter
- Becton, Dickinson and Company（BD）
- bioMerieux
- F. Hoffmann-La Roche Ltd
- Metabolomic Diagnostics Ltd
- Diabetomics, Inc.
- Quidel Corporation
- Sera Prognostics
- Brahms GmbH
- The Progenix Group

第10章分析师建议

升起和降落
综合机会图

第十一章参考文献与调查方法

参考
调查方法

简介目录

Product Code: CMI4606

Global preeclampsia diagnostics market is estimated to be valued at USD 2.10 Bn in 2024 and is expected to reach USD 4.12 Bn 2031, exhibiting a compound annual growth rate (CAGR) of 10.1% from 2024 to 2031.

Figure 1. Preeclampsia Diagnostics Market Share (%), By Region, 2024

Preeclampsia is a pregnancy complication characterized by high blood pressure and presence of protein in the urine after 20 weeks of gestation. It can be a dangerous condition for both mother and baby, if undetected. Early diagnosis is crucial to allow clinicians to closely monitor the condition and deliver the baby if preeclampsia worsens. Traditional diagnostic methods rely on clinical signs and symptoms, which have limitations. Global preeclampsia diagnostics market can witness growth due to increasing awareness about the condition. Various new diagnostic tools are being developed and adopted to screen women at risk and enable timely identification of the disorder.

Market Dynamics:

Global preeclampsia diagnostics market growth is driven by growing incidence of preeclampsia worldwide. According to recent estimates, preeclampsia complicates around 5-8% of all pregnancies globally. Rising maternal age of first-time mothers can contribute to its rising caseload. New product launches and increasing adoption of advanced diagnostic technologies for early screening can offer opportunities for market growth. However, limited awareness about preeclampsia in low income regions and lack of universal healthcare can hamper the market growth. High cost of new diagnostic devices can pose challenge, especially in price-sensitive developing markets.

Key Features of the Study:

This report provides in-depth analysis of the global preeclampsia diagnostics market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global preeclampsia diagnostics market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Roche, Thermo Fischer Scientific, Bayer, Siemens Healthineers, DRG Instruments GmbH
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global preeclampsia diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global preeclampsia diagnostics market

Detailed Segmentation-

By Test Type
- Blood Tests
- Urine Analysis
- Others
By Product Type
- Instruments
- Consumables
By End User
- Hospital
- Specialty Clinics
- Diagnostic Centers
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Roche Diagnostic
- Thermo Fisher Giving Inc.
- PerkinElmer
- Siemens Healthineers
- Abbott Laboratories
- Beckman Coulter
- Becton, Dickinson and Company (BD)
- bioMerieux
- Hoffmann-La Roche Ltd
- Metabolomic Diagnostics Ltd
- Diabetomics, Inc.
- Quidel Corporation
- Sera Prognostics
- Brahms GmbH
- The Progenix GrouP

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Test Type
- Market Snapshot, By Product Type
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Scenario
Acquisitions and Partnerships Scenario
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Preeclampsia Diagnostics Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the Market

5. Global Preeclampsia Diagnostics Market, By Test Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Blood Tests
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Urine Analysis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Preeclampsia Diagnostics Market, By Product Type, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Instruments
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Consumables
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Preeclampsia Diagnostics Market, By End User, 2019 - 2031, (USD Bn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2019 - 2031
- Segment Trends
Hospital
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Specialty Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Diagnostic Centers
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Preeclampsia Diagnostics Market, By Region, 2019 - 2031, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2019-2031
- Regional Trends
  - North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
  - GCC
  - Israel
  - Rest of Middle East
  - Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Test Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Company Profiles
- Roche Diagnostic
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Thermo Fisher Giving Inc.
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- PerkinElmer
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Siemens Healthineers
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Abbott Laboratories
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Beckman Coulter
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Becton, Dickinson and Company (BD)
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- bioMerieux
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- F. Hoffmann-La Roche Ltd
  - Company Highlights
  - Method Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Metabolomic Diagnostics Ltd
- Diabetomics, Inc.
- Quidel Corporation
- Sera Prognostics
- Brahms GmbH
- The Progenix Group

10. Analyst Recommendation

Wheel of Fortune
Analyst View
Coherent Opportunity Map

11. References and Research Methodology

References
Research Methodology
About Us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

妊娠毒血症诊断市场：按测试类型、按产品类型、按最终用户、按地区